11328 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices 

Anthropology. The human remains are 

a shovel shaped incisor with a groove 

between the enamel and the tooth root. 

No known individual was identified. No 

associated funerary objects are present. 

Museum records indicate that the 

Buick Camp Site represents a High 

Plains Upper Republican occupation. 

Radiocarbon analysis dates the Buick 

Camp Site to 664–770 A.D., which 

corresponds to the Plains Woodland 

Period. Archeologists identify the Upper 

Republican culture as ancestral Pawnee. 

Elbert County is within the cultural 

landscape of the Pawnee Nation. Based 

on archeological and historical 

evidence, the Buick Camp Site was 

situated in an area where bison were 

harvested at least bi-annually. 

Determinations Made by the University 

of Denver Museum of Anthropology 

Officials of the University of Denver 

Museum of Anthropology have 

determined that: 

• Pursuant to 25 U.S.C. 3001(9), the 

human remains described in this notice 

represent the physical remains of one 

individual of Native American ancestry. 

• Pursuant to 25 U.S.C. 3001(2), there 

is a relationship of shared group 

identity that can be reasonably traced 

between the Native American human 

remains and the Pawnee Nation of 

Oklahoma. 

Additional Requestors and Disposition 

Lineal descendants or representatives 

of any Indian Tribe or Native Hawaiian 

organization not identified in this notice 

that wish to request transfer of control 

of these human remains should submit 

a written request with information in 

support of the request to Anne Amati, 

University of Denver Museum of 

Anthropology, 2000 E Asbury Avenue, 

Sturm Hall 146, Denver, CO 80208, 

telephone (303) 871–2687, email 

anne.amati@du.edu, by March 26, 2021. 

After that date, if no additional 

requestors have come forward, transfer 

of control of the human remains to the 

Pawnee Nation of Oklahoma may 

proceed. 

The University of Denver Museum of 

Anthropology is responsible for 

notifying the Pawnee Nation of 

Oklahoma and The Invited Tribes that 

this notice has been published. 

Dated: February 5, 2021. 

Melanie O’Brien, 

Manager, National NAGPRA Program. 

[FR Doc. 2021–03716 Filed 2–23–21; 8:45 am] 

BILLING CODE 4312–52–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–797] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: AJC 

Industries, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefor, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 26, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW 8701 

Morrissette Drive, Springfield, Virginia 

22152. To ensure proper handling of 

comments, please reference Docket No. 

DEA–797 in all correspondence, 

including attachments. 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

file written comments on or objections 

of the requested registration, as 

provided in this notice. This notice does 

not constitute any evaluation or 

determination of the merits of the 

application submitted. 

The applicant plans to manufacture 

bulk active pharmaceutical ingredients 

(APIs) for product development and 

distribution to DEA-registered 

researchers. If the application for 

registration is granted, the registrant 

would not be authorized to conduct 

other activity under this registration 

aside from those coincident activities 

specifically authorized by DEA 

regulations. DEA will evaluate the 

application for registration as a bulk 

manufacturer for compliance with all 

applicable laws, treaties, and 

regulations and to ensure adequate 

safeguards against diversion are in 

place. 

As this applicant has applied to 

become registered as a bulk 

manufacturer of marihuana, the 

application will be evaluated under the 

criteria of 21 U.S.C. 823(a). DEA will 

conduct this evaluation in the manner 

described in the rule published at 85 FR 

82333 on December 18, 2020, and 

reflected in DEA regulations at 21 CFR 

part 1318. 

In accordance with 21 CFR 

1301.33(a), DEA is providing notice that 

on January 14, 2021, AJC Industries Inc., 

19469 County Road H, Ordway, 

Colorado 81063–9739, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substances: 

Controlled 

substance 

Drug 

code Schedule 

Marihuana extraxt ........... 7350 I 

Marihuana ....................... 7360 I 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–03755 Filed 2–23–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–794] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: GGGYI 

LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices 11329 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefor, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 26, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW 8701 

Morrissette Drive, Springfield, Virginia 

22152. To ensure proper handling of 

comments, please reference Docket No. 

DEA–794 in all correspondence, 

including attachments. 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

file written comments on or objections 

of the requested registration, as 

provided in this notice. This notice does 

not constitute any evaluation or 

determination of the merits of the 

application submitted. 

The applicant plans to manufacture 

bulk active pharmaceutical ingredients 

(APIs) for product development and 

distribution to DEA-registered 

researchers. If the application for 

registration is granted, the registrant 

would not be authorized to conduct 

other activity under this registration 

aside from those coincident activities 

specifically authorized by DEA 

regulations. DEA will evaluate the 

application for registration as a bulk 

manufacturer for compliance with all 

applicable laws, treaties, and 

regulations and to ensure adequate 

safeguards against diversion are in 

place. 

As this applicant has applied to 

become registered as a bulk 

manufacturer of marihuana, the 

application will be evaluated under the 

criteria of 21 U.S.C. 823(a). DEA will 

conduct this evaluation in the manner 

described in the rule published at 85 FR 

82333 on December 18, 2020, and 

reflected in DEA regulations at 21 CFR 

part 1318. 

In accordance with 21 CFR 

1301.33(a), DEA is providing notice that 

on January 25, 2021, GGGYI LLC, 4168 

South Drexel Boulevard 2A, Chicago, 

Illinois 60653, applied to be registered 

as a bulk manufacturer of the following 

basic class(es) of controlled substances: 

Controlled 

substance 

Drug 

code Schedule 

Marihuana Extract ................... 7350 I 

Marihuana ............................... 7360 I 

Tetrahydrocannabinols ........... 7370 I 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–03754 Filed 2–23–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–770] 

Bulk Manufacturer of Controlled 

Substances Application: Sigma Aldrich 

Research Biochemicals, Inc 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sigma Aldrich Research 

Biochemicals, Inc, has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 26, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 26, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on December 17, 2020, 

Sigma Aldrich Research Biochemicals, 

Inc, 400–600 Summit Drive, Burlington, 

Massachusetts 01803, applied to be 

registered as a bulk manufacturer of the 

following basic classes of controlled 

substances: 

Controlled substance Drug code Schedule 

Cathinone ........................................................................................................................................................................ 1235 I 

4-Methyl-N-Methylcathinone ............................................................................................................................................ 1248 I 

Methaqualone .................................................................................................................................................................. 2565 I 

JWH-018 & AM678 .......................................................................................................................................................... 7118 I 

Lysergic Acid Diethylamide ............................................................................................................................................. 7315 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

Mescaline ......................................................................................................................................................................... 7381 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 

Alpha-Methyltryptamine ................................................................................................................................................... 7432 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

5-Methoxy-N,N-Diisopropyltryptamine ............................................................................................................................. 7439 I 

1-Benzylpiperazine .......................................................................................................................................................... 7493 I 

2-(2,5-Dimethoxyphenyl) Ethanamine ............................................................................................................................. 7517 I 

3,4-Methylenedioxypyrovalerone ..................................................................................................................................... 7535 I 

3,4-Methylenedioxy-N-Methylcathinone .......................................................................................................................... 7540 I 

Heroin .............................................................................................................................................................................. 9200 I 

Normorphine .................................................................................................................................................................... 9313 I 

Norlevorphanol ................................................................................................................................................................ 9634 I 

Amphetamine ................................................................................................................................................................... 1100 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Nabilone ........................................................................................................................................................................... 7379 II 

Phencyclidine ................................................................................................................................................................... 7471 II 

Cocaine ............................................................................................................................................................................ 9041 II 


khammond on DSKJM1Z7X2PROD with NOTICES